Signaling via MYD88 in the pancreatic tumor microenvironment A double-edged sword

被引：14

作者：

Zambirinis, Constantinos P. ^{[1
]}

Miller, George ^{[1
,2
]}

机构：

[1] NYU, Dept Surg, S Arthur Localio Lab, Sch Med, New York, NY 10016 USA

[2] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA

来源：

ONCOIMMUNOLOGY | 2013年 / 2卷 / 01期

关键词：

cancer-associated inflammation; dendritic cells; innate immunity; MYD88; pancreatic cancer; pattern-recognition receptors; Toll-like receptors; tumor microenvironment; NEGATIVE REGULATION;

D O I：

10.4161/onci.22567

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We have recently shown that Toll-like receptor (TLR) signaling exacerbates pancreatic fibro-inflammation and promotes carcinogenesis in mice. Paradoxically, inhibition of the TLR-MYD88 signaling pathway is pro-tumorigenic owing to the dendritic cell-mediated T(H)2-polarization of CD4(+) T cells. TLR signaling appears to be central in pancreatic cancer-associated inflammation.

引用

页数：3

共 50 条

[31] The Adjuvant Effect of Emerging Nanomaterials: A Double-Edged Sword
Ren, Hong
Zhang, Quanxuan
Qie, Liangyi
Baker, Gregory L.
INTERACTIONS OF NANOMATERIALS WITH EMERGING ENVIRONMENTAL CONTAMINANTS, 2013, 1150 : 3 - 21
[32] Immunotherapy and epithelial ovarian cancer: a double-edged sword?
Ray-Coquard, I.
Lorusso, D.
ANNALS OF ONCOLOGY, 2017, 28 (05) : 909 - 910
[33] Hypothalamic inflammation: a double-edged sword to nutritional diseases
Cai, Dongsheng
Liu, Tiewen
YEAR IN DIABETES AND OBESITY, 2011, 1243 : E1 - E39
[34] Mast cells: a double-edged sword in inflammation and fibrosis
Wang, Xufang
Zhang, Peipei
Tang, Yuxin
Chen, Yanlin
Zhou, Enchao
Gao, Kun
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
[35] 5 Immune system: a double-edged sword in cancer
Narendra, Bodduluru Lakshmi
Reddy, Kasala Eshvendar
Shantikumar, Saladi
Ramakrishna, Sistla
INFLAMMATION RESEARCH, 2013, 62 (09) : 823 - 834
[36] Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells
Norozi, Fatemeh
Ahmadzadeh, Ahmad
Shahrabi, Saeid
Vosoughi, Tina
Saki, Najmaldin
TUMOR BIOLOGY, 2016, 37 (09) : 11679 - 11689
[37] Tumor-Associated Macrophages/Microglia in Glioblastoma Oncolytic Virotherapy: A Double-Edged Sword
Blitz, Sarah E.
Kappel, Ari D.
Gessler, Florian A.
Klinger, Neil V.
Arnaout, Omar
Lu, Yi
Peruzzi, Pier Paolo
Smith, Timothy R.
Chiocca, Ennio A.
Friedman, Gregory K.
Bernstock, Joshua D.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
[38] Differential role of MyD88 and TRIF signaling in myeloid cells in the pathogenesis of autoimmune diabetes
Androulidaki, Ariadne
Wachsmuth, Laurens
Polykratis, Apostolos
Pasparakis, Manolis
PLOS ONE, 2018, 13 (03):
[39] MyD88 signaling pathways: role in breast cancer
Zheng, Hongmei
Wu, Xinhong
Guo, Liantao
Liu, Jianhua
FRONTIERS IN ONCOLOGY, 2024, 14
[40] Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells
Luo, Shahang
Yang, Guanghui
Ye, Peng
Cao, Nengqi
Chi, Xiaoxia
Yang, Wen-Hao
Yan, Xiuwen
BIOMOLECULES, 2022, 12 (06)

← 1 2 3 4 5 →